A phase I study of the combination of gemcitabine (G), vinorelbine (V) and cisplatin (P) in patients (pts) with solid tumors.

被引：0
|
作者：
Schrijvers, D [1 ]
Dyck, J [1 ]
Van den Brande, J [1 ]
Wilmes, P [1 ]
Korst, A [1 ]
Lardon, F [1 ]
Vermorken, J [1 ]
机构：
[1] Univ Antwerp Hosp, Dept Med Oncol, Edegem, Belgium
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
642P
引用
收藏
页码：140 / 140
页数：1
相关论文
共 50 条
  • [21] A phase I study of oral uracil/ftorafur (UFT) plus leukovorin in combination with weekly paclitaxel (P) in patients (pts) with solid tumors.
    Mayer, F
    von Pawel, J
    Beck, J
    Schroeder, M
    Hartmann, JT
    Kanz, L
    Bokemeyer, C
    ANNALS OF ONCOLOGY, 2000, 11 : 136 - 136
  • [22] Phase IB study of sorafenib in combination with gemcitabine and cisplatin in patients with refractory solid tumors
    Schultheis, B.
    Kummer, G.
    Zeth, M.
    Brendel, E.
    Xia, C.
    Kornacker, M.
    Strumberg, D.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (02) : 333 - 339
  • [23] Phase IB study of sorafenib in combination with gemcitabine and cisplatin in patients with refractory solid tumors
    B. Schultheis
    G. Kummer
    M. Zeth
    E. Brendel
    C. Xia
    M. Kornacker
    D. Strumberg
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 333 - 339
  • [24] COMBINATION STUDY OF NAVITOCLAX (ABT-263) WITH GEMCITABINE (G) IN PATIENTS (PTS) WITH SOLID TUMORS
    Rocha-Lima, C.
    Shapiro, G. I.
    Hurwitz, H.
    Montero, A.
    Franklin, C.
    Xiong, H.
    Chiu, Y.
    Krivoshik, A. P.
    Uronis, H.
    ANNALS OF ONCOLOGY, 2010, 21 : 181 - 181
  • [25] Phase I study of SU5416 in combination with CPT-11 and cisplatin in patients with solid tumors.
    Kraut, EH
    Bender, J
    Clinton, S
    Jensen, R
    Balcerzak, S
    Chan, K
    Mueller, C
    Vaswani, K
    Mantil, J
    Christian, B
    Grever, M
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3661S - 3661S
  • [26] Final results of a phase I and pharmacokinetic (PK) study of OSI-7904L in combination with cisplatin (CDDP) in patients (pts) with advanced solid tumors.
    Ricart, AD
    Berlin, JD
    Syed, S
    Papadopoulos, K
    Drolet, D
    Quaratino-Baker, C
    Horan, J
    Chick, J
    Vermeulen, W
    Tolcher, AW
    Rowinsky, EK
    Rothenberg, ML
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9004S - 9005S
  • [27] A phase I clinical study of biweekly pemetrexed and gemcitabine in patients with advanced solid tumors.
    Dudek, A
    Larson, T
    Mellskog, CE
    Bloss, LP
    Obasaju, C
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 162S - 162S
  • [28] A phase I study to assess the safety, tolerability, and PK of dovitinib (D) in combination with gemcitabine (G) and capecitabine (C) in patients with advanced solid tumors.
    Fetterly, Gerald J.
    Pitzonka, Laura
    Zhao, Yujle
    Dy, Grace K.
    Iyer, Renuka V.
    Taubes, Susan
    Perez, Jose Ricardo
    Culver, Kenneth W.
    Wilton, John
    Monglardo, Krystin
    Tan, Wei
    Brady, William E.
    Whitworth, Amy
    Adjei, Alox A.
    Ma, Wen Wee
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [29] Phase I study of sorafenib (S) with bevacizumab (B) and paclitaxel (P) in patients (pts) with refractory solid tumors.
    Chiorean, E. G.
    Matei, D.
    Younger, A.
    Funke, J. M.
    Waddell, M. J.
    Jones, D. R.
    Hahn, N. M.
    Perkins, S. M.
    Sandrasegaran, K.
    Sweeney, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [30] A phase I clinical and pharmacokinetic (PK) study of paclitaxel (P) and docetaxel (D) in patients (PTS) with solid tumors.
    Izquierdo, MA
    Pontón, JL
    García, M
    Navarro, M
    Mesia, R
    Cardenal, F
    Gil, M
    Germá, JR
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S84 - S84
12345